The NT-ProBNP Test in Subjects with End-Stage Renal Disease on Hemodialysis Presenting with Acute Dyspnea: Is Knowing Worth the Cost?

Background. The NT-ProBNP/BNP test has been validated as a marker for determining the etiology of acute dyspnea. In the setting of end-stage renal disease on hemodialysis (ESRD on HD), the utility of the NT-ProBNP/BNP test has not been validated. This study examines the clinical utility of the NT-Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mok, Shaffer R. S., Avila, Jose, Milcarek, Barry, Kasama, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606718/
https://www.ncbi.nlm.nih.gov/pubmed/23533765
http://dx.doi.org/10.1155/2013/836497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606718/
https://www.ncbi.nlm.nih.gov/pubmed/23533765
http://dx.doi.org/10.1155/2013/836497

Ejemplares similares